Department of Oral and Maxillofacial surgery Université d'Auvergne, NHE - CHU de Clermont-Ferrand 1 place Lucie Aubrac, 63000 Clermont-Ferrand, France
Med Oral Patol Oral Cir Bucal. 2021 Jan 1;26(1):e28-e35. doi: 10.4317/medoral.23926.
Numerous biochemical datas support the noxious role of anti-inflammatory drugs on immune response. Those observations are often put forward for unfavorable evolution of odontogenic infection but has never been really proven in clinic. The aim of this study is to try to clarify this role based on the collection of the clinical course of odontogenic infections over a 10-year analysis period.
The investigators implemented a prospective observational study. The sample was composed of patients managed between January 2004 and December 2014 for severe odontogenic infection based on three criteria: hospital admission, intravenous antibiotic therapy, tooth extraction and collections drainage under general anesthesia. Clinical and pharmacological data were collected at admission, during hospitalization until discharged home. The population was first separated into two groups patients with or without anti-inflammatory drugs on admission, then on four groups (non-steroidal anti-inflammatory drugs, corticosteroids drugs, both and none on admission). Analysis were performed each time by univariate analysis, multivariate analysis and propensity score matching.
Six hundred and fifty-three patients were included in the study, 329 (50%) patients report orally anti-inflammatory treatment before presenting to hospital, 50 (7.6%) received corticosteroids, 242 (37%) received NSAIDs and 37 (5.6%) both. Evolution is worsening for patients under anti-inflammatory drugs in term of hospitalization in ICU (p=0.016), number of surgeries (p=0.003), risk of tracheotomy (p=0.036), duration of hospitalization (p=0.005) and spaces involved by the infection (p<0.001). When separating patients into 4 groups, dysphonia and odynophagia are more frequent for patients under corticosteroid and NSAID (35.14%, p<0.001), mediastinal erythema is more frequent for patients under corticosteroid (16%, p=0.004), fever is more frequent for patients under NSAID (35.5%, p=0.032), pain is higher for patients under corticosteroids (p=0.024). But, in order to reduce bias, linked to factors of gravity, a regression weighted by propensity scores was performed and any group of patients is different from the others.
Patients under anti-inflammatory drugs have more severe dental infection on admission and their complex evolution seems to be linked to the severity of infection on admission.
大量生化数据表明,抗炎药物会对免疫反应产生有害影响。这些观察结果通常被认为会导致牙源性感染的不良发展,但尚未在临床上得到真正证实。本研究旨在通过收集 10 年分析期间牙源性感染的临床病程,尝试阐明这一作用。
研究者进行了一项前瞻性观察研究。该样本由 2004 年 1 月至 2014 年 12 月期间因严重牙源性感染而住院的患者组成,入选标准为:住院治疗、静脉使用抗生素治疗、拔牙及全身麻醉下引流。在入院时、住院期间直至出院时收集临床和药理学数据。首先将人群分为两组:入院时使用或未使用抗炎药物的患者,然后分为四组(非甾体抗炎药、皮质类固醇药物、入院时同时使用两种药物和均未使用药物)。每次分析均进行单变量分析、多变量分析和倾向评分匹配。
本研究共纳入 653 例患者,329 例(50%)患者在就诊前口服抗炎药物治疗,50 例(7.6%)患者接受皮质类固醇治疗,242 例(37%)患者接受 NSAIDs 治疗,37 例(5.6%)患者同时接受两种药物治疗。与未使用抗炎药物的患者相比,使用抗炎药物的患者在 ICU 住院(p=0.016)、手术次数(p=0.003)、气管切开风险(p=0.036)、住院时间(p=0.005)和感染涉及的部位(p<0.001)方面病情恶化。当将患者分为四组时,接受皮质类固醇和 NSAIDs 治疗的患者出现声音嘶哑和吞咽困难的频率更高(35.14%,p<0.001),接受皮质类固醇治疗的患者出现纵隔红斑的频率更高(16%,p=0.004),接受 NSAIDs 治疗的患者出现发热的频率更高(35.5%,p=0.032),接受皮质类固醇治疗的患者疼痛程度更高(p=0.024)。但是,为了减少与疾病严重程度相关的偏倚,我们进行了基于倾向评分的回归加权,结果发现任何一组患者与其他组患者均不同。
入院时使用抗炎药物的患者牙源性感染更为严重,其复杂的病情发展似乎与入院时感染的严重程度有关。